Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB)

CUSIP: 83422E105

Q1 2022 13F Holders as of 31 Mar 2022

Holder snapshot 7 signals
Share change
-6,234,370
Put/Call ratio
40%
SEC-reported price per share
$1.20
Number of holders
73
Value change
-$8,045,281
Number of buys
21
Open additional details 1 more signal available
Number of sells
47
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
100,767,588

Security key

83422E105

Report period

Q1 2022

Institutions

73

Top holders

10

Ownership snapshot

Top reported holders of SLDB - Solid Biosciences Inc. - Common Stock $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Dec 2021
13F Lead comparable stake: 13% Showing 1-6 of 15 holder rows.

Quick read

PERCEPTIVE ADVISORS LLC leads the comparable SEC ownership view at 13%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Comparable ownership Top 5
PERCEPTIVE ADVISORS LLC 13%
RA CAPITAL MANAGEMENT, L.P. 12%
EcoR1 Capital, LLC 9.1%
Bain Capital Life Sciences Invest... 7.9%
SUVRETTA CAPITAL MANAGEMENT, LLC 6.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PERCEPTIVE ADVISORS LLC
13F
Company
13F
13%
$23,472,000
13,412,552 shares
31 Dec 2021
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
12%
$21,644,000
12,367,873 shares
31 Dec 2021
EcoR1 Capital, LLC
13F
Company
13F
9.1%
$16,105,000
9,202,702 shares
31 Dec 2021
Bain Capital Life Sciences Investors, LLC
13F
Company
13F
7.9%
$13,877,000
7,929,918 shares
31 Dec 2021
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
13F
6.2%
$11,003,000
6,287,193 shares
31 Dec 2021
BlackRock Finance, Inc.
13F
Company
13F
6.2%
$10,942,000
6,253,012 shares
31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
73
Shares
69,295,383
Rows available
73
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2026 Across Filers

Q1 2026 holders
7
Q1 2022 holders
73
Holder diff
66
Investor Q1 2026 Shares Q1 2022 Shares Share Diff Share Chg % Q1 2026 value Q1 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .